Literature DB >> 10225592

Prevention agenda for genital herpes.

H H Handsfield1, K M Stone, J N Wasserheit.   

Abstract

Few meeting participants envisioned a prevention and control program on the scale or scope of CDC's programs to prevent HIV infection, syphilis, gonorrhea, and chlamydial infection, but all agreed that the virtual absence of public health interventions to prevent genital herpes is no longer appropriate in light of evolving epidemiologic knowledge and other research advances. The ultimate scope of a national genital herpes prevention effort will depend in part on the results of the recommended research agenda, which probably will evolve over the better part of a decade. Numerous other STD prevention partners will also need to contribute to this effort and help to determine the makeup of future programs. Substantial new fiscal resources will be required both to implement the proposed research agenda and, depending on the results, to undertake the prevention efforts indicated by those studies. Competing STD prevention priorities and other national health needs will influence the availability of those resources. The consultants' meeting and the research and program activities summarized above are described in more detail in the full meeting report, which is posted on the Division's web site (www.cdc.gov/nchstp/dstd/dstdp.html) or may be requested directly from the Division. DSTDP is interested in receiving comments and suggestions about herpes prevention.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225592     DOI: 10.1097/00007435-199904000-00009

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  8 in total

Review 1.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

2.  Public Health Strategies to Prevent Genital Herpes: Where Do We Stand?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

3.  Racial/ethnic disparities in undiagnosed infection with herpes simplex virus type 2.

Authors:  Enrique R Pouget; Trace S Kershaw; Kim M Blankenship; Jeannette R Ickovics; Linda M Niccolai
Journal:  Sex Transm Dis       Date:  2010-09       Impact factor: 2.830

4.  Performance of focus ELISA tests for HSV-1 and HSV-2 antibodies among university students with no history of genital herpes.

Authors:  Hayley D Mark; Joy P Nanda; Jessica Roberts; Anne Rompalo; Johan H Melendez; Jonathan Zenilman
Journal:  Sex Transm Dis       Date:  2007-09       Impact factor: 2.830

5.  The Canadian Paediatric Surveillance Program: Beyond collecting numbers.

Authors:  J A Doherty; D Grenier
Journal:  Paediatr Child Health       Date:  2001-05       Impact factor: 2.253

6.  A mucosal vaccination approach for herpes simplex virus type 2.

Authors:  Rebecca S Tirabassi; Christopher I Ace; Tatyana Levchenko; Vladimir P Torchilin; Liisa K Selin; Siwei Nie; Dennis L Guberski; Kejian Yang
Journal:  Vaccine       Date:  2010-12-04       Impact factor: 3.641

7.  Genital herpes serotesting: a study of the epidemiology and patients' knowledge and attitude among STD clinic attenders in Coventry, UK.

Authors:  N Narouz; P S Allan; A H Wade; S Wagstaffe
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

8.  Serologic detection of herpes simplex virus type 2 antibodies among pregnant women using a point-of-care test from Focus Diagnostics.

Authors:  Bridget Leyland; Margaret R Kennedy; Yolanda H Wimberly; Bruce J Levine; Thomas L Cherpes
Journal:  J Clin Virol       Date:  2009-01-07       Impact factor: 3.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.